To date, TrkA signaling has been intensively dissected for tumors of the neuroectodermal lineage like neuroblastomas where, although TrkA is overexpressed through genomic rearrangements and can contribute to tumor onset, it seems to have a protective effect against later unfavorable outcome [4]. This evidence concerns the gene NTRK1 and neoplasm.